Harnessing the Body's own army: new cell therapy trial fights advanced skin cancer

NCT ID NCT00338377

Summary

This study is testing a personalized treatment for people with metastatic melanoma, a serious form of skin cancer that has spread. Doctors take a patient's own immune cells, grow them in large numbers in a lab, and then infuse them back into the patient to attack the cancer. The main goal is to see if adding special 'dendritic' cells to this treatment helps the immune cells last longer and work better against tumors.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MELANOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • The University of Texas MD Anderson Cancer Center

    Houston, Texas, 77030, United States

Conditions

Explore the condition pages connected to this study.